IMNM: Immunome, Inc. Company Short-Term Debt
Immunome, Inc. (IMNM) is integrating ESG principles into the development of immune-based medicines, strictly adhering to bioethics and environmental safety. However, high acquisition risks and R&D expenditures pose a threat to liquidity, with the indicator standing at 0.00. The price action on GURU.Markets clearly demonstrates the market valuation of the company, which generates revenue through partnerships and plans to sell advanced antibodies for cancer treatment.
Metric breakdowns and analytics for Immunome Bio (IMNM)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Immunome, Inc.|IMNM - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Immunome, Inc.|IMNM - Company Total Debt|Debt to Book Capitalization Ratio Immunome, Inc.|IMNM - Company Long-Term Liabilities|Company Current Liabilities Immunome|Quick Liquidity immunome.com
- net income and valuation multiples indicators:
Initial company analysis:IMNM - Immunome
This indicator assesses the total volume of credit obligations due for repayment within twelve months. The dynamics of short-term financial liabilities allow for the determination of real liquidity and the risk of working capital deficits. The calculation is based on the sum of term loans and current debt obligations to creditors. For Immunome, Inc. (IMNM), a low debt level confirms financial stability. This ensures the resources necessary to develop the oncology pipeline and implement strategic partnerships.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|Upstream Bio Corp - Company Short-Term Debts|Short-Term Debt Volume Zenas Corp ZBIO|Gossamer Bio, Inc. (GOSS) - Company Short-Term Debt|Company Current Liabilities kalvista.com|Company Short-Term Debt Septerna|Company Current Liabilities Pieris Pharma (PVLA)|Company Current Liabilities SVRA (Savara Corp)|Company Short-Term Debts Rigel Corp (RIGL)|Company Short-Term Debt AnaptysBio, Inc. ANAB|ATXS: Company Short-Term Indebtedness|ENGN - Company Short-Term Debt|Short-Term Debt rapt.com|aerovatetx.com (JBIO) - Company Short-Term Debt|Company Current Liabilities Aclaris Therapeutics, Inc|KYTX (Kyverna Therapeutics) - Company Short-Term Debts|Short-Term Debt tizianalifesciences.com TLSA|Company Current Liabilities CABA (Cabaletta Bio)|VTYX (Ventyx Biosciences Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debts THTX (Theratechnologies Inc)|Short-Term Debt Volume Avalo Therapeutics Inc (AVTX)|ELDN - Company Short-Term Debt|AGEN (agenusbio.com) - Company Short-Term Indebtedness|CLYM: Company Short-Term Debts|Company Current Liabilities zurabio.com|Company Current Liabilities ATYR|Adagene Corp (ADAG) - Short-Term Debt Volume|Company Short-Term Debts IMA|Short-Term Debt Volume shattucklabs.com|Company Short-Term Debt Equillium EQ|CNTB - Company Current Liabilities|IMUX - Company Short-Term Debt|ATRA (Atara Biotherapeutics) - Company Short-Term Indebtedness|inflarx.de (IFRX) - Company Short-Term Debt|Company Current Liabilities x4pharma.com|Company Short-Term Debt Adicet Bio Inc.|Celularity Corp - Current Liabilities|Company Short-Term Debts INMB|BRNS (Barinthus Biotherapeutics Corp) - Company Short-Term Loans and Borrowings|Company Short-Term Debts KZR (Kezar Life Sciences)|Company Short-Term Debts sabbiotherapeutics.com SABS|AKTX - Company Short-Term Debt|Company Short-Term Loans and Borrowings ENLV (Enlivex Therapeutics)|q32bio.com (QTTB) - Company Short-Term Debt|Company Current Liabilities GeoVax Corp|EDSA (Edesa Biotech, Inc.) - Company Short-Term Debts|Company Short-Term Debts ibioinc.com|Company Current Liabilities CARM (Carisma Therapeutics)|XTLB (XTL Biopharmaceuticals Ltd) - Company Short-Term Loans and Borrowings|Company Short-Term Debts BOLT (Bolt Biotherapeutics, Inc.)|Short-Term Debt Volume HCW Biologics, Inc. (HCWB)|APVO - Company Short-Term Debt|aimimmuno.com (AIM) - Company Current Liabilities|aditxt.com (ADTX) - Company Short-Term Debt|Company Current Liabilities GRI Bio Inc|Company Current Liabilities XRTX|Company Short-Term Debts Vyome Therapeutics|Company Short-Term Debt Revelation Biosciences (REVB)|indaptusrx.com - Company Short-Term Indebtedness|Company Short-Term Debts SCNI (Scinai Immunotherapeutics Ltd.)|CalciMedica Inc (CALI) - Short-Term Debt|Affimed Therapeutics - Company Short-Term Debts|Short-Term Debt Volume Allakos Inc. ALLK|hookipapharma.com (HOOK) - Company Short-Term Debt|Company Current Liabilities IGM Biosciences|Company Short-Term Debt iTeos Therapeutics, Inc.|Company Current Liabilities Ocean Biomedical Inc (OCEA)|Company Current Liabilities TCBP (TC BioPharm (Holdings) PLC)|Company Short-Term Debts Third Harmonic Bio Inc (THRD)